[Current status of symptomatic therapy of allergic rhinitis].
The mode of action of different groups of anti-allergic drugs is described in relation to our current knowledge of the pathomechanism of allergic immediate and late-phase reactions. Recent developments in the therapy of allergic rhinitis are discussed. Knowledge of the principal effects and the clinical properties of the drugs represents the basis for the use of the different compounds.
Bachert
C
C
HNO-Klinik, Klinikum Mannheim der Universität Heidelberg.
Colberg
C
C
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008407:Mast Cells / Q000187:drug effects; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D006634:Histamine H1 Antagonists; D004205:Cromolyn Sodium
Gegenwärtiger Stand der symptomatischen Therapie bei der allergischen Rhinitis.